1. Home
  2. MERLOT Materials
  3. Material Detail: Pfizer Analysis Makes Case For COVID Vaccine Booster

Material Detail

Pfizer Analysis Makes Case For COVID Vaccine Booster

Pfizer Analysis Makes Case For COVID Vaccine Booster

Pfizer says data support its request for Food and Drug Administration approval of a third dose of COVID vaccine about six months after the second dose in people 16 years and older.

Keywords:
boosters, COVID-19
Disciplines:
Go to Material 
Bookmark / Add to Course ePortfolio
Create a Learning Exercise
Add Accessibility Information
Rate
Add a Comment

Quality

  • User Rating
  • Comments
  • Learning Exercises
  • Bookmark Collections
  • Course ePortfolios
  • Accessibility Info

More about this material

Material Type:
Reference Material
Date Added to MERLOT:
September 15, 2021
Date Modified in MERLOT:
September 15, 2021
Author:
Unknown (Know the author?)
Submitter:
Mary Bemker
Primary Audience:
College General Ed, College Lower Division, College Upper Division
Technical Format:
Website
Mobile Compatibility:
Not specified at this time
Technical Requirements:
Accessed via Google Chrome
Language:
English
Cost Involved:
No
Source Code Available:
Yes
Creative Commons:
Unknown

Browse...

Disciplines with similar materials as Pfizer Analysis Makes Case For COVID Vaccine Booster
People who viewed this also viewed
Other materials like Pfizer Analysis Makes Case For COVID Vaccine Booster

Comments

Log in to participate in the discussions or sign up if you are not already a MERLOT member.